Replies to post #124478 on Biotech Values

[DewDiligence]

The willingness of non-government third-party payers to pay for Provenge might not be as inelastic as you think.

[AlpineBV_Miller]

I think any change in price, but especially one upwards, would be distasteful. I agree with PGS on that one :)